Aug 30, 2024 | Laboratory UTCBS, Research
Suresnes, August 29, 2024 – 8am CET – Neovacs (Euronext Growth Paris : ALNEV), a preclinical-stage biopharmaceutical company developing novel therapies for inflammatory and autoimmune diseases, is honored to be listed among the latest CNRS publications...
Aug 22, 2024 | Laboratory UTCBS, Research
Gene Electrotransfer via Conductivity-Clamped Electric Field Focusing Pivots Sensori-Motor DNA Therapeutics: “A Spoonful of Sugar Helps the Medicine Go Down” https://doi.org/10.1002/advs.202401392
Jul 11, 2024 | Laboratory UTCBS, Symposium
UTCBS presents its work at the international congress of the “controlled release society” in Bologna. The UTCBS team has shown the interest of nanoparticles both for the imaging of ROS in vivo and the promotion of antioxydant therapeutic activity....
Jun 20, 2024 | Laboratory UTCBS
The Alnylam Pharmaceuticals 2024 “Interfering RNA & Rare Diseases” Prize has been awarded to Virginie Escriou, for her research entitled “Therapeutic strategies based on orally administered siRNA”. The prize was delivered at the Annual...
Jun 14, 2024 | Laboratory UTCBS, Research
On Friday June 7, the UTCBS students’ day took place at the Faculty of Pharmacy, organized by the laboratory’s PhD students. The day was an opportunity for students and post-docs to talk about their studies and training. During the event, we had the...
May 3, 2024 | Laboratory UTCBS, Research
The LHF Espoir and Artistes Sportifs de Coeur associations presented a cheque to the biotherapy team to support its research project, which aims to administer mRNA to restore the expression of the missing protein in genetic diseases such as Microvillous Inclusion...
